Publisher
Computers, Materials and Continua (Tech Science Press)
Reference24 articles.
1. Aapro MS, van Wijk FH, Bolis G, et al. (2003) Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol 14: 441–448
2. Aghajanian C, Sill MW, Darcy K, et al. (2009) A phase II evaluation of bevacizumab in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group (GOG) study. J Clin Oncol 27(15s): Abstract 5531
3. Bookman MA, Brady MF, McGuire WP, et al. (2009) Evaluation of new platinumbased treatment regimens in advancedstage ovarian cancer: a phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol 27(9): 1419–1425
4. Cobleigh MA, Langmuir VK, Sledge GW, et al. (2003) A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol 30(16s): 117–124
5. Conte PF, Favalli G, Gadducci A, et al. (2007) Final results of after-6 protocol 1: a phase III trial of observation versus six courses of paclitaxel in advanced ovarian cancer patients in complete response after platinum-paclitaxel chemotherapy. J Clin Oncol 25(18s): Abstract 5505